Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies

Age Related Multiple Sclerosis Severity Score: Disability ranked by age

(2017) Ali Manouchehrinia et al.   Multiple Sclerosis Journal

Age Related Multiple Sclerosis Severity Score: Disability ranked by age

(2017) Ali Manouchehrinia et al.   Multiple Sclerosis Journal

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

(2016) Peter Alping et al.   ANNALS OF NEUROLOGY

Improved treatment satisfaction after switching therapy to rituximab in relapsing–remitting MS

(2016) Pierre de Flon et al.   Multiple Sclerosis Journal

Rituximab in multiple sclerosis

(2016) Jonatan Salzer et al.   NEUROLOGY

Improved treatment satisfaction after switching therapy to rituximab in relapsing–remitting MS

(2016) Pierre de Flon et al.   Multiple Sclerosis Journal

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

(2016) Delphine Bachelet et al.   PLoS One

The Swedish MS registry - clinical support tool and scientific resource

(2015) J. Hillert et al.   ACTA NEUROLOGICA SCANDINAVICA

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial

(2008) Amit Bar-Or et al.   ANNALS OF NEUROLOGY

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

(2007) Thomas Tiller et al.   JOURNAL OF IMMUNOLOGICAL METHODS